Stage III Nasopharyngeal Carcinoma
Semantic Scholar uses AI to extract papers important to this topic.
We investigated treatment results, the effects of different treatment modality, and pretreatment Epstein‐Barr virus (EBV) viral… Expand Introduction:
Nasopharyngeal carcinoma (NPC) is a rare malignancy with an incidence of 0.5-2 per 100,000 in Europe and the… Expand Objective Our objective was to examine whether adding induction chemotherapy to concurrent chemoradiotherapy improved survival in… Expand OBJECTIVE
To evaluate the efficacy and toxicity of Yanshu injection (a compound Chinese traditional medicine from Sophora… Expand OBJECTIVE:To evaluate the impacts of chemotherapy combined with radiotherapy on the survival of patients suffered from stage… Expand Objective To explore the effect of nursing intervention in patients with advanced nasopharyngeal carcinoma treated with combined… Expand 5510 Background: Concomitant chemoradiotherapy (CCRT) is considered to be the most effective way to improve overall survival in… Expand OBJECTIVE
To investigate p53 protein expression at stage III nasopharyngeal differentiated non-keratinizing squamous carcinoma… Expand OBJECTIVE
To study the relationship between macrophages (MP), Langerhans cells (LC), T and B lymphocytes, biological behavior and… Expand A prospectively randomized, double-blind clinical trial was conducted to evaluate the effect of immunotherapy with transfer… Expand